rs786204790
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_000369.5(TSHR):c.545+2_545+3delTG variant causes a splice donor, splice region, intron change. The variant allele was found at a frequency of 0.0000149 in 1,613,684 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000369.5 splice_donor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSHR | NM_000369.5 | c.545+2_545+3delTG | splice_donor_variant, splice_region_variant, intron_variant | Intron 6 of 9 | ENST00000298171.7 | NP_000360.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSHR | ENST00000298171.7 | c.545_545+1delTG | p.Leu182GlnfsTer29 | frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant | Exon 6 of 10 | 1 | NM_000369.5 | ENSP00000298171.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461504Hom.: 0 AF XY: 0.0000124 AC XY: 9AN XY: 727064
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Hypothyroidism due to TSH receptor mutations Pathogenic:1
The c.545+2_545+3del variant in TSHR has not been reported in individuals with disease or in large population studies. This variant occurs in the invariant region (+/- 1/2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Biallelic loss-of-function variants in the TSHR gene have been shown to cause thyroid-stimulating hormone resistance (see review by Cassio 2013). Although there are multiple cases identified with only a single heterozygous pathogenic variant, insufficient evidence exists to determine if a true carrier phenotype is possible or if these studies simply did not find the second variant. In summary, this novel variant is likely to be pathogenic in a recessive manner for TSH resistance, though additional studies are required to fully establish its clinical significance. -
not provided Pathogenic:1
This sequence change affects a splice site in intron 6 of the TSHR gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TSHR are known to be pathogenic (PMID: 8954020). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TSHR-related conditions. ClinVar contains an entry for this variant (Variation ID: 189249). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at